These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4310180)

  • 21. Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA.
    Park JH; Baron S
    Science; 1968 Nov; 162(3855):811-3. PubMed ID: 4301068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic-polycytidylic acid duplex and its mismatched analogues. III. Chronic effects and immunological features.
    Carter WA; O'Malley J
    Mol Pharmacol; 1976 May; 12(3):440-53. PubMed ID: 180397
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiviral activity and side effects of polyriboinosinic-cytidylic acid complexes as affected by molecular size.
    Morahan PS; Munson AE; Regelson W; Commerford SL; Hamilton LD
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):842-6. PubMed ID: 4337241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo antiviral effects of pidotimod.
    Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
    Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Corynebacterium granulosum-derived P40 immunomodulator exerts a synergistic effect on the activity of antiviral drugs in the treatment of experimental viral infections.
    Fattal-German M; Bizzini B
    Biomed Pharmacother; 1988; 42(3):217-20. PubMed ID: 3179407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiviral activity of the antibiotic rubomycin].
    Bliumberg NA; Kalamova NI
    Antibiotiki; 1967 Oct; 12(10):898-903. PubMed ID: 4297491
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of the protective effect against Mengo virus infection in mice of interferons induced by polyI:C and Mengo virus.
    Campbell JB; Buera JG
    Can J Microbiol; 1971 Dec; 17(12):1525-32. PubMed ID: 4333910
    [No Abstract]   [Full Text] [Related]  

  • 28. [Viral myocarditis].
    Pansini R; Farinelli A; Longhini C
    Recenti Prog Med; 1969 Dec; 47(6):489-548. PubMed ID: 4314292
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of sonication on physicochemical and biological properties of synthetic double-stranded polyribonucleotides as interferon inducer.
    Shiokawa K; Yaoi H
    Arch Gesamte Virusforsch; 1972; 38(2):109-24. PubMed ID: 4352302
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiviral and cytotoxic effects of mycophenolic acid.
    Planterose DN
    J Gen Virol; 1969 Jun; 4(4):629-30. PubMed ID: 4308492
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of interferon in experimental viral diseases].
    German A; Quero AM
    Bull Acad Natl Med; 1983 Feb; 167(2):163-9. PubMed ID: 6196097
    [No Abstract]   [Full Text] [Related]  

  • 32. Herpes simplex encephalitis: virologic and serologic study of a patient treated with an interferon inducer.
    Bellanti JA; Catalano LW; Chambers RW
    J Pediatr; 1971 Jan; 78(1):136-45. PubMed ID: 4321599
    [No Abstract]   [Full Text] [Related]  

  • 33. Nature of the antiviral activity of statolon.
    Prince HN; Grunberg E
    Antimicrob Agents Chemother (Bethesda); 1965; 5():588-92. PubMed ID: 4286924
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced viral infection in the mouse treated with 6-mercaptopurine.
    St Geme JW; Brumbaugh JL; Pajari KL; Singer AD; Toyama PS
    J Lab Clin Med; 1970 Aug; 76(2):213-20. PubMed ID: 5434002
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of interferon and host resistance in vivo by double-stranded complexes of copolyribonucleotide of isosinic and guanylic with polyribocytidylic acid.
    Matsuda S; Kida M; Shirafuji H; Yoneda M; Yaoi H
    Arch Gesamte Virusforsch; 1971; 34(2):105-18. PubMed ID: 4345742
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of interferons and interferonogens in dermatology (a review)].
    Shcherbakov IM
    Vestn Dermatol Venerol; 1973 Mar; 47(3):8-13. PubMed ID: 4581062
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiviral substances. Thiosemicarbazones. Discussion.
    Ann N Y Acad Sci; 1965 Jul; 130(1):128-34. PubMed ID: 5216625
    [No Abstract]   [Full Text] [Related]  

  • 38. Viruses and interferon: a fight for supremacy.
    Katze MG; He Y; Gale M
    Nat Rev Immunol; 2002 Sep; 2(9):675-87. PubMed ID: 12209136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral viral infections and the therapeutic use of antiviral agents in dentistry.
    McCullough MJ; Savage NW
    Aust Dent J; 2005 Dec; 50(4 Suppl 2):S31-5. PubMed ID: 16416715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. II. Effect of multiple doses of polyriboinosinic-polyribocytidylic acid on viral pathogenesis.
    Stringfellow DA; Overall JC; Glasgow LA
    J Infect Dis; 1974 Nov; 130(5):481-8. PubMed ID: 4371529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.